Interaction and regulatory functions of μ-And δ-opioid receptors in nociceptive afferent neurons

Neuroscience Bulletin

Volumn 28, Issue 2, 2012, Pages 121-130

  Zhang, Xu ^a   Bao, Lan ^b  

^a Institute of Neuroscience and State Key Laboratory of Neuroscience   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Nociceptive pathways; Opioid receptor; Peripheral nervous system

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; METHADONE; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; SUBSTANCE P;

ANALGESIC ACTIVITY; ANTINOCICEPTION; CELL INTERACTION; CELLULAR DISTRIBUTION; DRUG EFFICACY; DRUG TOLERANCE; GENE FUNCTION; HUMAN; INTERNALIZATION; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; NERVE CELL MEMBRANE; NEUROMODULATION; NEUROPATHOLOGY; NOCICEPTIVE PAIN; NOCICEPTIVE STIMULATION; NONHUMAN; PHARMACOLOGICAL STIMULATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR AFFINITY; REVIEW; SENSORY NERVE;

AFFERENT PATHWAYS; ANIMALS; CHRONIC PAIN; GANGLIA, SPINAL; HUMANS; NOCICEPTORS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 84862777895     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-012-1206-x     Document Type: Review

References (95)

1. Mennicken F, Zhang J, Hoffert C, Ahmad S, Beaudet A, O'Donnell D. Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia. J Comp Neurol 2003, 465: 349-360. (Pubitemid 37174200)
2. Besse D, Lombard MC, Perrot S, Besson JM. Regulation of opioid binding sites in the superficial dorsal horn of the rat spinal cord following loose ligation of the sciatic nerve: comparison with sciatic nerve section and lumbar dorsal rhizotomy. Neuroscience 1992, 50: 921-933.
3. Moskowitz AS, Goodman RR. Light microscopic autoradiographic localization of μ and δ opioid binding sites in the mouse central nervous system. J Neurosci 1984, 4: 1331-1342. (Pubitemid 14076088)
4. Gouarderes C, Beaudet A, Zajac JM, Cros J, Quirion R. High resolution radioautographic localization of[125I]FK-33-824-labelled mu opioid receptors in the spinal cord of normal and deafferented rats. Neuroscience 1991, 43: 197-209.
5. Fields HL, Emson PC, Leigh BK, Gilbert RF, Iversen LL. Multiple opiate receptor sites on primary afferent fibres. Nature 1980, 284: 351-353. (Pubitemid 10122188)
6. Ueda M, Sugimoto K, Oyama T, Kuraishi Y, Satoh M. Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices. Neuropharmacology 1995, 34: 303-308.
7. Zachariou V, Goldstein BD. δ-Opioid receptor modulation of the release of substance P-like immunoreactivity in the dorsal horn of the rat following mechanical or thermal noxious stimulation. Brain Res 1996, 736: 305-314. (Pubitemid 26356489)
8. Minami M, Maekawa K, Yabuuchi K, Satoh M. Double in situ hybridization study on coexistence of μ-, δ-, and ?-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root gang lia. Mol Brain Res 1995, 30: 203-210.
9. Wang H, Wessendorf MW. Equal proportions of small and large DRG neurons express opioid receptor mRNAs. J Comp Neurol 2001, 429: 590-600. (Pubitemid 32011855)
10. Wang HB, Zhao B, Zhong YQ, Li KC, Li ZY, Wang Q, et al. Coexpression of δ-and μ-opioid receptors in nociceptive sensory neurons. Proc Natl Acad Sci U S A 2010, 107: 13117-13122.
11. He SQ, Zhang ZN, Guan JS, Liu HR, Zhao B, Wang HB, et al. Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation. Neuron 2011, 69: 120-131.
12. Gaveriaux-Ruff C, Nozaki C, Nadal X, Hever XC, Weibel R, Matifas A, et al. Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain 2011, 152: 1238-1248.
13. Standifer KM, Chien CC, Wahlestedt C, Brown GP, Pasternak GW. Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor. Neuron 1994, 12: 805-810. (Pubitemid 24126241)
14. Nitsche JF, Schuller AG, King MA, Zengh M, Pasternak GW, Pintar JE. Genetic dissociation of opiate tolerance and physical dependence in delta-opioid receptor-1 and preproenkephalin knockout mice. J Neurosci 2002, 22: 10906-10913. (Pubitemid 36005166)
15. Zhu Y, King MA, Schuller AG, Nitsche JF, Reidl M, Elde RP, et al. Retention of supraspinal δ-like analgesia and loss of morphine tolerance in δ opioid receptor knockout mice. Neuron 1999, 24: 243-252. (Pubitemid 29466162)
16. Arvidsson U, Dado RJ, Riedl M, Lee JH, Law PY, Loh HH, et al. δ-opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci 1995, 15: 1215-1235.
17. Guan JS, Xu ZZ, Gao H, He SQ, Ma GQ, Sun T, et al. Interaction with vesicle luminal protachykinin regulates surface expression of δ-opioid receptors and opioid analgesia. Cell 2005, 122: 619-631. (Pubitemid 41191159)
18. Gupta A, Decaillot FM, Gomes I, Tkalych O, Heimann AS, Ferro ES, et al. Conformation state-sensitive antibodies to G-proteincoupled receptors. J Biol Chem 2007, 282: 5116-5124. (Pubitemid 47093768)
19. Gupta A, Rozenfeld R, Gomes I, Raehal KM, Decaillot FM, Bohn LM, et al. Post-activation-mediated changes in opioid receptors detected by N-terminal antibodies. J Biol Chem 2008, 283: 10735-10744.
20. Micovic V, Ivanovic MD, Dosen-Micovic L. Docking studies suggest ligand-specific delta-opioid receptor conformations. J Mol Model 2009, 15: 267-280.
21. Petäjä-Repo UE, Hogue M, Leskelä TT, Markkanen PM, Tuusa JT, Bouvier M. Distinct subcellular localization for constitutive and agonist-modulated palmitoylation of the human δ opioid receptor. J Biol Chem 2006, 281: 15780-15789. (Pubitemid 43848468)
22. Scherrer G, Imamachi N, Cao YQ, Contet C, Mennicken F, O'Donnell D, et al. Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 2009, 137: 1148-1159.
23. Arvidsson U, Riedl M, Chakrabarti S, Lee JH, Nakano AH, Dado RJ, et al. Distribution and targeting of a μ opioid receptor (MOR1) in brain and spinal cord. J Neurosci 1995, 15: 3328-3341.
24. Zhang X, Bao L, Arvidsson U, Elde R, Hökfelt T. Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: evidence for association with the membrane of large dense-core vesicles. Neuroscience 1998, 82: 1225-1242. (Pubitemid 27502063)
25. Zhang X, Bao L, Shi TJ, Ju G, Elde R, Hökfelt T. Down-regulation of mu-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 1998, 82: 223-240.
26. Walwyn W, Maidment NT, Sanders M, Evans CJ, Kieffer BL, Hales TG. Induction of δ opioid receptor function by up-regulation of membrane receptors in mouse primary afferent neurons. Mol Pharmacol 2005, 68: 1688-1698. (Pubitemid 41654352)
27. Rau KK, Caudle RM, Cooper BY, Johnson RD. Diverse immunocytochemical expression of opioid receptors in electrophysiology cally defined cells of rat dorsal root ganglia. J Chem Neuroanatomy 2005, 29: 255-264. (Pubitemid 40775812)
28. Wu ZZ, Chen SR, Pan HL. Differential sensitivity of N-and P/ Q-type Ca2+ channel currents to a μ opioid in isolectin B4-positive and -negative dorsal root ganglion neurons. J Pharmacol Exp Ther 2004, 311: 939-947.
29. Ji RR, Zhang Q, Law PY, Low HH, Elde R, H?kfelt T. Expression of μ-, δ-, and ?-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 1995, 15: 8156-8166.
30. Bao L, Wang HF, Cai HJ, Tong YG, Jin SX, Lu YJ, et al. Peripheral axotomy induces only very limited sprouting of coarse myelinated afferents into inner lamina II of rat spinal cord. Eur J Neurosci 2002, 16: 175-185. (Pubitemid 36160238)
31. Joseph EK, Levine JD. Mu and delta opioid receptors on nociceptors attenuate mechanical hyperalgesia in rat. Neuroscience 2010, 171: 344-350.
32. Beaudry H, Dubois D, Gendron L. Activation of spinal μ-and δ-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli. J Neurosci 2011, 31: 13068-13077.
33. van Rijn RM, Brissett DI, Whistler JL. Emergence of functional spinal delta opioid receptors after chronic ethanol exposure. Biol Psychiatry 2012, 71: 232-238.
34. Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E, et al. Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal 2010, 3: ra54.
35. Zhang X, Bao L, Guan JS. Role of delivery and trafficking of δ-opioid peptide receptors in opioid analgesia and tolerance. Trends Pharmacol Sci 2006, 27: 324-329. (Pubitemid 44183608)
36. van Rijn RM, Whistler JL, Waldhoer M. Opioid-receptor-heteromerspecific trafficking and pharmacology. Curr Opin Pharmacol 2010, 10: 73-79.
37. Stockton SD Jr, Devi LA. Functional relevance of μ-δ opioid receptor heteromerization: A Role in novel signaling and implications for the treatment of addiction disorders. Drug Alcohol Depend 2012, 121 (3): 167-172.
38. Bao L, Jin SX, Zhang C, Wang LH, Xu ZZ, Zhang FX, et al. Activation of delta opioid receptors induces receptor insertion and neuropeptide secretion. Neuron 2003, 37: 121-133. (Pubitemid 36106439)
39. Zhao B, Wang HB, Lu YJ, Hu JW, Bao L, Zhang X. Transport of receptors, receptor signaling complexes and ion channels via neuropeptide-secretory vesicles. Cell Res 2011, 21: 741-753.
40. Cheng PY, Svingos AL, Wang H, Clarke CL, Jenab S, Beczkowska IW, et al. Ultrastructural immunolabeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin-and nonenkephalin-containing axon terminals in the superficial layers of the rat cervical spinal cord. J Neurosci 1995, 15: 5976-5988.
41. Zhang X, Bao L, Ma GQ. Sorting of neuropeptides and neuropeptide receptors into secretory pathways. Prog Neurobiol 2010, 90: 276-283.
42. Ma GQ, Wang B, Wang HB, Wang Q, Bao L. Short elements with charged amino acids form clusters to sort protachykinin into large dense-core vesicles. Traffic 2008, 9: 2165-2179.
43. Decaillot FM, Befort K, Filliol D, Yue S, Walker P, Kieffer BL. Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation. Nat Struct Biol 2003, 10: 629-636. (Pubitemid 36944716)
44. Meng F, Ueda Y, Hoversten MT, Thompson RC, Taylor L, Watson SJ, et al. Mapping the receptor domains critical for the binding selectivity of delta-opioid receptor ligands. Eur J Pharmacol 1996, 311: 285-292. (Pubitemid 26330386)
45. Pepin MC, Yue SY, Roberts E, Wahlestedt C, Walker P. Novel "restoration of function" mutagenesis strategy to identify amino acids of the delta-opioid receptor involved in ligand binding. J Biol Chem 1997, 272: 9260-9267.
46. Varga EV, Li X, Stropova D, Zalewska T, Landsman RS, Knapp RJ, et al. The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists. Mol Pharmacol 1996, 50: 1619-1624. (Pubitemid 26425119)
47. Wang WW, Shahrestanifar M, Jin J, Howells RD. Studies on mu and delta opioid receptor selectivity utilizing chimeric and sitemutagenized receptors. Proc Natl Acad Sci U S A 1995, 92: 12436-12440. (Pubitemid 26014084)
48. Gendron L, Lucido AL, Mennicken F, O'Donnell D, Vincent JP, Stroh T, et al. Morphine and pain-related stimuli enhance cell surface availability of somatic δ-opioid receptors in rat dorsal root ganglia. J Neurosci 2006, 26: 953-962. (Pubitemid 43239576)
49. Ma J, Zhang Y, Kalyuzhny AE, Pan ZZ. Emergence of functional delta-opioid receptors induced by long-term treatment with morphine. Mol Pharmacol 2006, 69: 1137-1145.
50. Cahill CM, Morinville A, Lee MC, Vincent JP, Collier B, Beaudet A. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci 2001, 21: 7598-7607. (Pubitemid 32904959)
51. Patwardhan AM, Berg KA, Akopain AN, Jeske NA, Gamper N, Clarke WP, et al. Bradykinin-induced functional competence and trafficking of the δ-opioid receptor in trigeminal nociceptors. J Neurosci 2005, 25: 8825-8832. (Pubitemid 41384450)
52. Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, Laustriat D, Cao YQ, et al. Knockin mice expressing fluorescent δ-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci U S A 2006, 103: 9691-9696. (Pubitemid 43955886)
53. Li KC, Zhang FX, Li CL, Wang F, Yu MY, Zhong YQ, et al. Follistatin-like 1 suppresses sensory afferent transmission by activating Na+,K+-ATPase. Neuron 2011, 69: 974-987.
54. Hamada K, Matsuura H, Sanada M, Toyoda F, Omatsu-Kanbe M, Kashiwagi A, et al. Properties of the Na+/K+ pump current in small neurons from adult rat dorsal root ganglia. Br J Pharmacol 2003, 138: 1517-1527. (Pubitemid 36609647)
55. Mata M, Siegel GJ, Hieber V, Beaty MW, Fink DJ. Differential distribution of Na,K-ATPase alpha isoform mRNAs in the peripheral nervous system. Brain Res 1991, 546: 47-54.
56. Wu ZZ, Cai YQ, Pan HL. A functional link between T-type calcium channels and μ-opioid receptor expression in adult primary sensory neurons. J Neurochem 2009, 109: 867-878.
57. Deng H, Yang Z, Li Y, Bao G, Friedrich T, Gu Q, et al. Interactions of Na+,K+-ATPase and co-expressed delta-opioid receptor. Neurosci Res 2009, 65: 222-227.
58. Heinke B, Gingl E, Sandkuhler J. Multiple targets of μ-opioid receptor-mediated presynaptic inhibition at primary afferent Aδ-and C-fibers. J Neurosci 2011, 31: 1313-1322.
59. Jordan BA, Trapaidze N, Gomes I, Nivarthi R, Devi LA. Oligomerization of opioid receptors with β2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci U S A 2001, 98: 343-348. (Pubitemid 32095911)
60. Jordan BA, Gomes I, Rios C, Filipovska J, Devi LA. Functional interactions between μ opioid and ?2A-adrenergic receptors. Mol Pharmacol 2003, 64: 1317-1324. (Pubitemid 37532221)
61. Overland AC, Kitto KF, Chabot-Dore AJ, Rothwell PE, Fairbanks CA, Stone LS, et al. Protein kinase C mediates the synergistic interaction between agonists acting at ?2-adrenergic and delta-opioid receptors in spinal cord. J Neurosci 2009, 29: 13264-13273.
62. Petäjä-Repo UE, Hogue M, Bhalla S, Laperriere A, Morello JP, Bouvier M. Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. EMBO J 2002, 21: 1628-1637. (Pubitemid 34614619)
63. Bie B, Zhang Z, Cai YQ, Zhu W, Zhang Y, Dai J, et al. Nerve growth factor-regulated emergence of functional δ-opioid receptors. J Neurosci 2010, 30: 5617-5628.
64. Margolis EB, Mitchell JM, Hjelmstad GO, Fields HL. A novel δ opioid receptor-mediated enhancement of GABAA receptor function induced by stress in ventral tegmental area neurons. J Physiol 2011, 589: 4229-4242.
65. Milan-Lobo L, Whistler JL. Heteromerization of the μ-and δ-opioid receptors produces ligand-biased antagonism and alters μ-receptor trafficking. J Pharmacol Exp Ther 2011, 337: 868-875.
66. Cesselin F, Bourgoin S, Clot AM, Hamon M, Le Bars D. Segmental release of Met-enkephalin-like material from the spinal cord of rats, elicited by noxious thermal stimuli. Brain Res 1989, 484: 71-77. (Pubitemid 19100067)
67. Cheng ZJ, Yu QM, Wu YL, Ma L, Pei G. Selective interference of β-arrestin 1 with ? and δ but not μ opioid receptor/G protein coupling. J Biol Chem 1998, 273: 24328-24333. (Pubitemid 28454920)
68. Rozenfeld R, Devi LA. Receptor heterodimerization leads to a switch in signaling: β-arrestin2-mediated ERK activation by μ-δ opioid receptor heterodimers. FASEB J 2007, 21: 2455-2465. (Pubitemid 47230675)
69. Chao D, Xia Y. Ionic storm in hypoxic/ischemic stress: can opioid receptors subside it? Prog Neurobiol 2010, 90: 439-470.
70. Pradhan AA, Befort K, Nozaki C, Gaveriaux-Ruff C, Kieffer BL. The delta opioid receptor: an evolving target for the treatment of brain disorders. Trends Pharmacol Sci 2011, 32: 581-590.
71. Berger AC, Whistler JL. How to design an opioid drug that causes reduced tolerance and dependence. Ann Neurol 2010, 67: 559-569.
72. Kim HJ, Seol TK, Lee HJ, Yaksh TL, Jun JH. The effect of intrathecal mu, delta, kappa, and alpha-2 agonists on thermal hyperalgesia induced by mild burn on hind paw in rats. J Anesth 2011, 25: 884-891.
73. Janecka A, Fichna J, Janecki T. Opioid receptors and their ligands. Curr Top Med Chem 2004, 4: 1-17. (Pubitemid 38842558)
74. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician 2008, 11: S133-153. (Pubitemid 351682083)
75. Matthes HW, Smadja C, Valverde O, Vonesch JL, Foutz AS, Boudinot E, et al. Activity of the δ-opioid receptor is partially reduced, whereas activity of the ?-receptor is maintained in mice lacking the μ-receptor. J Neurosci 1998, 18: 7285-7295. (Pubitemid 28425813)
76. Scherrer G, Befort K, Contet C, Becker J, Matifas A, Kieffer BL. The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice. Eur J Neurosci 2004, 19: 2239-2248. (Pubitemid 38582212)
77. van Rijn RM, Whistler JL. The δ1 opioid receptor is a heterodimer that opposes the actions of the δ2 receptor on alcohol intake. Biol Psychiatry 2009, 66: 777-784.
78. Dubois D, Gendron L. Delta opioid receptor-mediated analgesia is not altered in preprotachykinin A knockout mice. Eur J Neurosci 2010, 32: 1921-1929.
79. Wrigley PJ, Jeong HJ, Vaughan CW. Dissociation of μ-and δ-opioid inhibition of glutamatergic synaptic transmission in superficial dorsal horn. Mol Pain 2010, 6: 71.
80. Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008, 11: S63-88. (Pubitemid 351682079)
81. Fields HL. The doctor's dilemma: opiate analgesics and chronic pain. Neuron 2011, 69: 591-594.
82. Fields H. State-dependent opioid control of pain. Nat Rev Neurosci 2004, 5: 565-575. (Pubitemid 38868552)
83. Abdelhamid EE, Sultana M, Portoghese PS, Takemori AE. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther 1991, 258: 299-303.
84. Schiller PW. Bi-or multifunctional opioid peptide drugs. Life Sci 2010, 86: 598-603.
85. Schiller PW, Fundytus ME, Merovitz L, Weltrowska G, Nguyen TM, Lemieux C, et al. The opioid μ agonist/δ antagonist DIPPNH2[ &PSI] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats. J Med Chem 1999, 42: 3520-3526. (Pubitemid 29445087)
86. Schiller PW, Weltrowska G, Berezowska I, Nguyen TM, Wilkes BC, Lemieux C, et al. The TIPP opioid peptide family: development of δ antagonists, δ agonists, and mixed μ agonist/δ antagonists. Biopolymers 1999, 51: 411-425. (Pubitemid 30262485)
87. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, et al. Oligomerization of μ-and δ-opioid receptors. Generation of novel functional properties. J Biol Chem 2000, 275: 26128-26135.
88. Jordan BA, Devi LA. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999, 399: 697-700. (Pubitemid 29289066)
89. Law PY, Erickson-Herbrandson LJ, Zha QQ, Solberg J, Chu J, Sarre A, et al. Heterodimerization of μ-and δ-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J Biol Chem 2005, 280: 11152-11164. (Pubitemid 40418422)
90. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA. A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 2004, 101: 5135-5139. (Pubitemid 38469214)
91. Xie WY, He Y, Yang YR, Li YF, Kang K, Xing BM, et al. Disruption of Cdk5-associated phosphorylation of residue threonine-161 of the δ-opioid receptor: impaired receptor function and attenuated morphine antinociceptive tolerance. J Neurosci 2009, 29: 3551-3564.
92. Minneman KP. Heterodimerization and surface localization of G protein coupled receptors. Biochem Pharmacol 2007, 73: 1043-1050. (Pubitemid 46413168)
93. He L, Fong J, von Zastrow M, Whistler JL. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 2002, 108: 271-282. (Pubitemid 34161146)
94. Yu YJ, Dhavan R, Chevalier MW, Yudowski GA, von Zastrow M. Rapid delivery of internalized signaling receptors to the somatodendritic surface by sequence-specific local insertion. J Neurosci 2010, 30: 11703-11714.
95. Puthenveedu MA, Lauffer B, Temkin P, Vistein R, Carlton P, Thorn K, et al. Sequence-dependent sorting of recycling proteins by actinstabilized endosomal microdomains. Cell 2010, 143: 761-773.